QUALITY OF LIFE IN PATIENTS SUFFERING FROM SECONDARY OSTEOPOROSIS DUE TO SERONEGATIVE SPONDYLOARTHROPATHIES

Aim and objectives: To point out the importance of complex treatment in patients suffering from secondary osteoporosis due to seronegative spondyloarthropathies. Material and methods: During a one year period we studied 128 patients suffering from secondary osteoporosis due to seronegative spondyloarthropathies divided into two homogenous groups. Group 1 followed medical treatment of the primary rheumatic disease and anti-osteoporotic therapy, while group 2 followed in addition a home-adapted kinetotherapy programme. Each patient was assessed 7 times (complex clinical examination, laboratory tests for inflammation, disease activity score, functional score and quality of life scale). Results: We noticed an increased BMD, normalisation of inflammation tests at 12 weeks, no progression of radiological aspects and a better quality of life in group 2 patients. Conclusions: Medical therapy of seronegative spondyloarthropathies including anti-osteoporotic treatment combined with an individualized home-adapted programme improves quality of life and increases BMD.